Platform combines proprietary AI sequence optimization, novel genetic parts, and lab validation in application-relevant cell models to improve expression and half-life, delivering top candidates in ...

Ractigen Therapeutics, a pioneering clinical-stage biotechnology company developing innovative small activating RNA (saRNA) therapeutics, today announced that China's National Medical Products ...

Nanoparticles that deliver self-amplifying RNA were found to reduce scarring and improve heart function in animals following ...

The FDA awards Fast Track designation to BW-20805 for hereditary angioedema, a therapy designed to reduce attacks through PKK suppression.

With AI, it's now possible for researchers to predict the three-dimensional structures of proteins directly from their ...

When Novartis agreed to buy RNA therapies developer Avidity Biosciences last fall, the companies said the plan was to spin out Avidity’s cardiology assets into a separate, publicly traded company.

This reflects the confidence pharmaceutical innovators place in Pyramid’s expanded state-of-the-art facility to deliver ...

A new RNA-based therapy developed at Columbia University could help the heart repair itself after a heart attack without invasive surgery.

India, March 17 -- A breakthrough RNA therapy helps the heart protect and heal itself from the damage following the heart ...

We recently published 10 Shares Explode as Earnings Impress. Avidity Biosciences, Inc. (NASDAQ:RNA) is one of the best-performing stocks on Friday. Avidity Biosciences saw its share prices increase by ...

Researchers have found that targeted delivery of messenger RNA (mRNA) can restore sperm production and fertility in genetically infertile male mice. The findings, published in Stem Cell Reports, ...